Suppr超能文献

在有四名或更多受影响的一级亲属的家庭中的炎症性肠病。

Inflammatory bowel disease in families with four or more affected first-degree relatives.

作者信息

Boaz Elad, Bar-Gil Shitrit Ariella, Schechter Menachem, Goldin Eran, Reissman Petachia, Yellinek Shlomo, Koslowsky Benjamin

机构信息

Department of General Surgery, Faculty of Medicine, Hebrew University of Jerusalem, Shaare-Zedek Medical Center, Jerusalem, Israel.

Faculty of Medicine, Hebrew University of Jerusalem, Digestive Diseases Institute, Shaare Zedek Medical Center, Jerusalem, Israel.

出版信息

Scand J Gastroenterol. 2023 Jan;58(1):20-24. doi: 10.1080/00365521.2022.2106153. Epub 2022 Aug 5.

Abstract

BACKGROUND

Family history increases the risk for inflammatory bowel diseases (IBDs). However, data on differences in phenotypic characteristics among patients with a strong family history of IBD are scarce and controversial. The aim of the study was to compare the phenotypic features of IBD patients with four or more affected first-degree relatives with sporadic cases of IBD.

METHODS

Patients with familial and sporadic IBD were identified from the institutional IBD database. IBD patients from families with at least four first-degree affected relatives were selected for analysis and were compared to non-matched sporadic cases with IBD chosen randomly. Comparison for type of IBD (Crohn's disease (CD) vs. ulcerative colitis (UC)), age at onset as well as for disease extent, behavior, extraintestinal manifestations and indicators of severe disease were analyzed.

RESULTS

Thirty-five patients with familial IBD (28 CD, seven UC) were compared to 88 sporadic IBD patients (61 CD, 24 UC and three IBDU). Disease duration was 10.3 ± 8.2 in the familial and 8.0 ± 7.2 years in the sporadic cases, =.13. The familial cases were younger at diagnosis (19.3 ± 8.6 vs. 25.7 ± 11.8, =.004). Patients with familial compared to sporadic IBD were significantly more likely to require steroid treatment (80% vs. 54.5%, =.009), biological treatment (94.3%, vs. 63.6%, <.001) or surgery (25.7%, vs. 11.4%, =.048).

CONCLUSIONS

IBD with a very strong positive family history is associated with younger age at onset and a more adverse IBD phenotype compared to sporadic IBD.

摘要

背景

家族病史会增加炎症性肠病(IBD)的发病风险。然而,关于炎症性肠病家族病史强烈的患者其表型特征差异的数据却很少且存在争议。本研究的目的是比较有四个或更多受影响的一级亲属的IBD患者与散发性IBD患者的表型特征。

方法

从机构IBD数据库中识别出家族性和散发性IBD患者。选择来自至少有四个一级亲属受影响的家庭的IBD患者进行分析,并与随机选择的非匹配散发性IBD病例进行比较。分析IBD类型(克罗恩病(CD)与溃疡性结肠炎(UC))、发病年龄以及疾病范围、行为、肠外表现和严重疾病指标。

结果

35例家族性IBD患者(28例CD,7例UC)与88例散发性IBD患者(61例CD,24例UC和3例未定型IBD)进行比较。家族性病例的病程为10.3±8.2年,散发性病例为8.0±7.2年,P = 0.13。家族性病例诊断时更年轻(19.3±8.6岁对25.7±11.8岁,P = 0.004)。与散发性IBD相比,家族性IBD患者更有可能需要类固醇治疗(80%对54.5%,P = 0.009)、生物治疗(94.3%对63.6%,P < 0.001)或手术(25.7%对11.4%,P = 0.048)。

结论

与散发性IBD相比,家族病史非常强阳性的IBD与发病年龄较小和更不良的IBD表型相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验